Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis

被引：20

作者：

Ang, Jocelyn Y. ^{[1
,2
]}

Abdel-Haq, Nahed ^{[1
,2
]}

Zhu, Frank ^{[1
,2
]}

Thabit, Abrar K. ^{[3
,4
]}

Nicolau, David P. ^{[3
,5
]}

Satlin, Michael J. ^{[6
,7
]}

van Duin, David ^{[8
]}

机构：

[1] Childrens Hosp Michigan, Div Infect Dis, Detroit, MI 48201 USA

[2] Wayne State Univ, Dept Pediat, Sch Med, Detroit, MI 48202 USA

[3] Hartford Hosp, Ctr Antiinfect Res & Dev, Hartford, CT USA

[4] King Abdulaziz Univ, Fac Pharm, Jeddah, Saudi Arabia

[5] Hartford Hosp, Div Infect Dis, Hartford, CT 06115 USA

[6] Weill Cornell Med, Div Infect Dis, New York, NY USA

[7] Weill Cornell Med, Transplantat Oncol Infect Dis Program, New York, NY USA

[8] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2016年 / 60卷 / 10期

关键词：

CEFTOLOZANE/TAZOBACTAM; PHARMACOKINETICS; PNEUMONIA; MEROPENEM; INFUSION;

D O I：

10.1128/AAC.00705-16

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We describe a pediatric cystic fibrosis patient who developed a pulmonary exacerbation due to two multidrug-resistant (MDR) Pseudomonas aeruginosa isolates. In addition to these MDR organisms, the case was further complicated by beta-lactam allergy. Despite the MDR phenotype, both isolates were susceptible to an antimicrobial combination.

引用

页码：5627 / 5630

页数：4

共 14 条

[1] Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore [J].

Ambrose, Paul G. ;

Bhavnani, Sujata M. ;

Rubino, Christopher M. ;

Louie, Arnold ;

Gumbo, Tawanda ;

Forrest, Alan ;

Drusano, George L. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) :79-86

[2] Pseudomonas aeruginosa: all roads lead to resistance [J].

Breidenstein, Elena B. M. ;

de la Fuente-Nunez, Cesar ;

Hancock, Robert E. W. .

TRENDS IN MICROBIOLOGY, 2011, 19 (08) :419-426

[3] Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study [J].

Chastre, Jean ;

Wunderink, Richard ;

Prokocimer, Philippe ;

Lee, Michael ;

Kaniga, Kone ;

Friedland, Ian .

CRITICAL CARE MEDICINE, 2008, 36 (04) :1089-1096

[4]

Hong Mai-Chi, 2013, Infect Drug Resist, V6, P215, DOI 10.2147/IDR.S36140

[5] Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis [J].

Kuti, Joseph L. ;

Pettit, Rebecca S. ;

Neu, Natalie ;

Cies, Jeffrey J. ;

Lapin, Craig ;

Muhlebach, Marianne S. ;

Novak, Kimberly J. ;

Nguyen, Sean T. ;

Saiman, Lisa ;

Nicolau, David P. .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (01) :53-55

[6] Impact of MIC Range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the Ceftolozane In Vivo Pharmacokinetic/Pharmacodynamic Target [J].

Lepak, A. J. ;

Reda, A. ;

Marchillo, K. ;

Van Hecker, J. ;

Craig, W. A. ;

Andes, D. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (10) :6311-6314

[7] Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy [J].

Lodise, Thomas P., Jr. ;

Lomaestro, Ben ;

Drusano, George L. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) :357-363

[8] Combination Treatment With Meropenem Plus Levofloxacin Is Synergistic Against Pseudomonas aeruginosa Infection in a Murine Model of Pneumonia [J].

Louie, Arnold ;

Liu, Weiguo ;

VanGuilder, Michael ;

Neely, Michael N. ;

Schumitzky, Alan ;

Jelliffe, Roger ;

Fikes, Steven ;

Kurhanewicz, Stephanie ;

Robbins, Nichole ;

Brown, David ;

Baluya, Dodge ;

Drusano, George L. .

JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (08) :1326-1333

[9]

Merck & Co. Inc, 2015, PROD INF ZERB INTR I

[10] High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection [J].

Oliver, A ;

Cantón, R ;

Campo, P ;

Baquero, F ;

Blázquez, J .

SCIENCE, 2000, 288 (5469) :1251-1253

← 1 2 →